# Intrathecal Neostigmine for Prevention of PDPH

> **NCT03587441** · PHASE4 · COMPLETED · sponsor: **Fayoum University Hospital** · enrollment: 240 (actual)

## Conditions studied

- Post-Dural Puncture Headache

## Interventions

- **DRUG:** Neostigmine Methylsulfate
- **DRUG:** Dextrose 5% in water

## Key facts

- **NCT ID:** NCT03587441
- **Lead sponsor:** Fayoum University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-04
- **Primary completion:** 2019-02-05
- **Final completion:** 2019-02-10
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2019-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03587441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03587441, "Intrathecal Neostigmine for Prevention of PDPH". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03587441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*